Skip to content Tirzepatide is a dual GIP/GLP-1 receptor agonist that a licensed provider may consider within a medically supervised weight-management plan. At Remedy in Maple Grove, MN, it starts with bloodwork and a clinical evaluation — never a retail purchase.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) and is the active ingredient in FDA-approved medications for chronic weight management in adults who meet specific criteria, and under another brand name for type 2 diabetes. Whether it’s appropriate for you is determined after your evaluation.
Recommendations grounded in your bloodwork.
Titrated and adjusted under licensed supervision.
Follow-ups track tolerability and response.
Benefits, risks, and alternatives explained before you begin.
Prescribed only within a provider–patient relationship.
One component of a broader, personalized plan.
After labs and a consultation, your provider determines whether tirzepatide is clinically appropriate. If so, they explain dosing, what to expect, and your monitoring schedule, then adjust the plan at follow-ups based on your response.
History, medications, goals, and bloodwork.
Eligibility assessed and options discussed.
If appropriate, prescribed with clear dosing and monitoring guidance.
Regular reviews to adjust safely.
Are an adult seeking supervised weight management.
Are willing to start with labs and stay engaged in follow-up.
Prefer clinical oversight over prescription-free products.
Are in general health with realistic expectations.
Eligibility is determined by your provider.
Prescribed only pursuant to a valid prescription after a legitimate provider–patient relationship. Considerations, including gastrointestinal effects, are reviewed at informed consent. No retail sales, no guaranteed outcomes; pricing upfront.
Tirzepatide acts on two receptors (GIP and GLP-1); semaglutide acts on one. Your provider will discuss which is appropriate for you — this page can’t determine that.
No. An evaluation and labs come first.
We prescribe FDA-approved medication. Compounded forms are used only where current FDA policy permits.
No one can promise that. Results vary and are discussed individually.
